Overview

Pharmacokinetic Study Comparing Aspirin and Effervescent Aspirin

Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
To determine the bioequivalence of new formula of aspirin relative to the established commercial effervescent aspirin when taken orally by healthy adult subjects
Phase:
Phase 1
Details
Lead Sponsor:
Bayer
Treatments:
Aspirin